We build computer vision systems for healthcare that analyze medical images, clinical photographs, surgical video, and clinical documents — from radiology AI assistants and pathology screening tools to wound assessment automation and clinical document digitization, all within HIPAA-compliant and FDA-aware architecture.

Computer vision in healthcare is not a general image recognition problem wearing a lab coat. Medical images contain subtle patterns that distinguish benign from malignant, normal from pathological, stable from deteriorating — patterns that require training data curated by clinical experts, model architectures designed for the specific imaging modality, and deployment architectures that fit into clinical imaging workflows rather than disrupting them. A general computer vision team can build an image classifier, but building a radiology AI system that integrates with PACS workflows, handles DICOM image formats with their complex metadata, operates within FDA Software as a Medical Device guidance, and delivers results that radiologists trust enough to incorporate into their clinical practice requires domain-specific expertise at every layer of the stack. At ZTABS, we build medical computer vision systems that combine state-of-the-art model architectures with the clinical workflow integration, regulatory awareness, and deployment infrastructure that healthcare demands.
The medical computer vision market reached $5.8 billion in 2024, driven by three converging forces: radiologist shortages (the U.S. faces a projected shortage of 5,000+ radiologists by 2030), increasing imaging volumes (diagnostic imaging volume grows 3-5% annually, outpacing radiologist workforce growth), and maturation of deep learning architectures that achieve clinician-level performance on specific tasks. The FDA has cleared over 800 AI/ML-enabled medical devices as of 2024, with radiology accounting for 75% of all clearances — demonstrating both the clinical readiness and the regulatory pathway for medical computer vision.
Radiology AI is the most established application. FDA-cleared algorithms exist for chest X-ray interpretation (pneumothorax detection, rib fracture detection, pulmonary nodule screening), mammography (breast density assessment, suspicious lesion detection), CT imaging (pulmonary embolism detection, coronary artery calcium scoring, liver lesion characterization), and MRI (brain tumor segmentation, knee ligament assessment). But the gap between FDA clearance and clinical adoption remains significant — studies show that less than 30% of radiology departments have deployed any AI algorithm in clinical production. The bottleneck is not model performance but workflow integration, PACS connectivity, radiologist trust, and sustainable business models for AI deployment.
Pathology AI is the fastest-growing segment. Digital pathology — scanning glass slides into whole-slide images (WSI) for computational analysis — enables AI applications for cancer screening (identifying regions of interest on tissue slides), grading (assessing tumor differentiation and staging), quantitative biomarker analysis (PD-L1 expression scoring, Ki-67 proliferation index), and quality assurance (flagging potentially missed findings on negative slides). The technical challenge is scale: a single whole-slide image at 40x magnification can exceed 100,000 × 100,000 pixels, requiring specialized architectures for efficient processing.
Beyond radiology and pathology, medical computer vision applications include dermatology (skin lesion classification, wound measurement and progression tracking), ophthalmology (diabetic retinopathy screening, glaucoma detection from retinal images), surgical video analytics (surgical phase recognition, instrument tracking, anomaly detection for quality improvement), clinical photography (wound assessment and measurement from smartphone photos), and document digitization (extracting structured data from scanned clinical documents, faxed referrals, and handwritten notes).
The regulatory landscape requires careful navigation. If your computer vision system provides diagnostic or treatment recommendations, it likely qualifies as Software as a Medical Device (SaMD) under FDA jurisdiction. The regulatory pathway depends on the risk classification: Class I (exempt from premarket review for low-risk applications), Class II (requiring 510(k) clearance with predicate device comparison and performance data), or Class III (requiring Premarket Approval with clinical trial evidence). The FDA's Predetermined Change Control Plan framework allows manufacturers to define anticipated model updates that can be implemented without new regulatory submissions — a critical consideration for systems that will be retrained on new data.
Our medical computer vision development follows a pipeline-oriented architecture with distinct stages for data preparation, model development, clinical validation, and deployment — each with healthcare-specific requirements that distinguish it from general computer vision work.
Data preparation for medical imaging requires clinical annotation expertise. We work with board-certified specialists (radiologists, pathologists, dermatologists) to create ground truth labels that reflect clinical judgment rather than lay interpretation. Annotation protocols specify the clinical criteria for each label (what constitutes a "positive" finding, what level of certainty constitutes a ground truth label, how borderline cases are handled). We implement multi-reader annotation with adjudication — each image is annotated by at least two clinicians, with disagreements resolved by a third senior clinician, ensuring label quality that reflects clinical consensus rather than individual variation. For DICOM images, we build preprocessing pipelines that handle the unique characteristics of medical imaging: windowing and leveling for CT images, multi-sequence handling for MRI, magnification calibration for pathology slides, and metadata extraction for clinical context.
Model architecture selection is guided by the specific imaging task. For classification tasks (normal vs. abnormal, benign vs. malignant), we use convolutional neural networks (EfficientNet, ConvNeXt) or vision transformers (ViT, Swin Transformer) fine-tuned from models pretrained on medical imaging datasets (RadImageNet, CheXpert) rather than ImageNet, because the visual patterns in medical images differ fundamentally from natural photographs. For detection tasks (localizing findings within an image), we implement architectures optimized for medical imaging (RetinaNet, DETR with domain-specific anchoring). For segmentation tasks (delineating tumor boundaries, measuring wound area), we use U-Net variants (nnU-Net, Swin-UNETR) that have demonstrated state-of-the-art performance on medical image segmentation benchmarks. For whole-slide pathology images, we implement multiple-instance learning (MIL) architectures that process the image in tiles and aggregate predictions, handling the extreme resolution of pathology slides efficiently.
Clinical validation goes beyond standard ML evaluation metrics. We evaluate models for diagnostic accuracy (sensitivity, specificity, positive predictive value, negative predictive value) at clinically meaningful operating points — not just AUC, but performance at thresholds that balance the clinical consequences of false positives and false negatives for the specific use case. We assess performance across patient demographics (age, sex, race), imaging equipment manufacturers (GE, Siemens, Philips, Canon), and acquisition parameters (different kVp settings, contrast administration, slice thickness) to identify subgroup performance variations. For applications targeting FDA clearance, we design validation studies that meet regulatory expectations: sufficient sample size, appropriate clinical comparators, and predefined acceptance criteria.
Deployment integrates with existing clinical imaging infrastructure. We build DICOM-native inference services that receive images from PACS through DICOM routing, process them through the model pipeline, and deliver results back to the clinical workflow — either as structured reports in the radiology worklist, as DICOM Secondary Capture images with AI annotations overlaid on the original image, or as clinical decision support alerts triggered by specific findings. For PACS integration, we support the DICOM standard communication protocols (C-STORE for image receipt, C-FIND for worklist queries) and AI-specific DICOM extensions (DICOM SR for structured reporting, DICOM SEG for segmentation results).
Free consultation — no commitment required.
A 200-bed community hospital's emergency department was experiencing radiology reporting delays averaging 2.4 hours for chest X-rays during night shifts and weekends (when on-site radiologist coverage dropped from 3 to 1). Critical findings — pneumothorax, large pleural effusions, wide mediastinum — required immediate clinical attention, but without triage, urgent studies waited in the same queue as routine films. An average of 3.2 critical chest X-ray findings per week were not identified by the ED physician before the formal radiology report, leading to delayed intervention in 15% of cases.
We built a chest X-ray triage AI system that analyzes every chest X-ray within 90 seconds of acquisition and assigns a priority score based on detected findings. The model — a ConvNeXt architecture fine-tuned on 380,000 chest X-rays with multi-label annotations for 14 findings — detects pneumothorax, pleural effusion, cardiomegaly, pulmonary edema, consolidation, mass/nodule, and other critical findings. Studies with critical findings are automatically escalated to the top of the radiologist worklist with AI-generated preliminary findings displayed alongside the image. The system integrates with the hospital's PACS (Philips IntelliSpace) through standard DICOM routing and worklist management protocols. AI results are displayed as overlay annotations on the original image and as structured preliminary reports in the radiology information system.
Average time to radiologist review for critical chest X-ray findings decreased from 2.4 hours to 18 minutes — a 92% reduction. The AI system achieved 94.2% sensitivity and 91.7% specificity for critical findings on a prospective validation set of 12,400 chest X-rays. Delayed treatment for critical chest X-ray findings decreased from 15% to 2.1% of cases. The ED adopted the AI triage into their standard workflow, with ED physicians using AI preliminary findings for immediate clinical decision-making while awaiting formal radiology interpretation. The system processes an average of 45 chest X-rays per day with a median inference time of 47 seconds from image acquisition to result delivery.
Real-time detection, classification, and counting of objects in images and video streams.
Extract structured data from documents, invoices, receipts, and forms with high accuracy.
Automated visual inspection for manufacturing defect detection with sub-second processing.
Real-time video stream analysis for surveillance, traffic monitoring, and retail analytics.
Train domain-specific models on your data using YOLO, Detectron2, SAM, and custom architectures.
Deploy vision models on edge devices (Jetson, Coral), mobile, or cloud with optimized inference.
Medical computer vision options include FDA-cleared AI products (Aidoc, Viz.ai, Lunit, Paige AI), cloud-based medical imaging AI platforms (Google Health AI, AWS HealthImaging with AI), academic/open-source models (TorchXRayVision, MONAI), and custom development. FDA-cleared products offer regulatory clearance and validated performance but limit you to their specific use cases, imaging modalities, and integration patterns — and charge per-study fees ($2-$15 per study) that create significant ongoing costs at high volume. Cloud platforms provide infrastructure but require custom model development. Open-source models provide starting architectures but require significant additional development for clinical-grade performance and deployment. ZTABS builds custom medical computer vision systems tailored to your specific clinical use cases, imaging equipment, and workflow integration requirements — with model architectures trained or fine-tuned on your patient population and deployment infrastructure you own without per-study licensing fees.
Medical computer vision projects range from $100,000 to $400,000 depending on model complexity, clinical validation requirements, and deployment scope. A focused computer vision application for a single imaging task with PACS integration runs $100,000-$180,000 across 16-24 weeks. Multi-model systems handling multiple imaging modalities or findings, with comprehensive clinical validation and FDA SaMD documentation support, typically fall in the $250,000-$400,000 range across 24-40 weeks. All projects include clinical annotation coordination, HIPAA-compliant training infrastructure, PACS integration, and prospective validation design.
Common questions about computer vision development for healthcare
It depends on the intended use. Systems that provide diagnostic recommendations (identifying pathology, suggesting diagnoses) generally require FDA clearance as Software as a Medical Device. Systems that perform triage (prioritizing worklist order without providing diagnostic conclusions), quality assurance (flagging studies for second review), or operational functions (measuring wound area, digitizing documents) may not require clearance. We help you determine the regulatory classification and, if clearance is needed, design the clinical validation study and prepare the submission documentation.
Our team has deep expertise in healthcare technology. Get a free consultation.